LoginSignup
Guardant Health logo

Guardant Health Stock

StockStock
ISIN: US40131M1099
Ticker: GH
US40131M1099
GH

Price

Frequently asked questions

What is Guardant Health's market capitalization?

The market capitalization of Guardant Health is $2.69B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Guardant Health?

Guardant Health's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$4.092. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Guardant Health's stock?

Currently, 22 analysts cover Guardant Health's stock, with a consensus target price of $36.17. Analyst ratings provide insights into the stock's expected performance.

What is Guardant Health's revenue over the trailing twelve months?

Over the trailing twelve months, Guardant Health reported a revenue of $643.81M.

What is the EBITDA for Guardant Health?

Guardant Health's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$468.04M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Guardant Health?

Guardant Health has a free cash flow of -$299.27M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Guardant Health's stock?

The 5-year beta for Guardant Health is 1.11. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Guardant Health have, and what sector and industry does it belong to?

Guardant Health employs approximately 1,779 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Guardant Health's shares?

The free float of Guardant Health is 117.39M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $2.69B

5Y beta

 1.11

EPS (TTM)

 -$4.092

Free Float

 117.39M

Revenue (TTM)

 $643.81M

EBITDA (TTM)

 -$468.04M

Free Cashflow (TTM)

 -$299.27M

Pricing

1D span
$21.85$22.10
52W span
$15.81$37.04

Analyst Ratings

The price target is $36.17 and the stock is covered by 22 analysts.

Buy

19

Hold

3

Sell

0

Information

Guardant Health, Inc. is a precision oncology company focused on guarding wellness and giving every person more time free from cancer. It provides critical insights into what drives disease through its advanced blood and tissue tests, real-world data, and artificial intelligence (AI) analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the best treatment for patients with advanced cancer. For patients with advanced-stage cancer, it has developed Guardant360 laboratory developed test (LDT), and Guardant360 CDx, a comprehensive liquid biopsy test to provide tumor mutation profiling with solid tumors and to be used as a companion diagnostic in connection with non-small cell lung cancer (NSCLC), and breast cancer. It offers other tests, including Guardant360 TissueNext tissue test, Guardant Reveal blood test, Guardant360 Response blood test and others.

1,779

Biotechnology & Drugs

Health Care

Identifier

ISIN

US40131M1099

Primary Ticker

GH

Knockouts

Join the conversation
Sign upLogin